Is Ambit’s ‘Sell’ Rating on Lenskart Justified Before Its Market Debut?
About Lenskart and the Ambit Report
Ambit Capital has begun coverage on Lenskart with a Sell rating, just ahead of the company’s listing on November 10. The brokerage flagged valuation concerns even as the eyewear retailer continues its aggressive domestic and global expansion. Ambit expects nearly 20% revenue CAGR between FY25 and FY28, backed by growth in both India and international markets.
The firm highlighted a mismatch between Lenskart’s growth story and its return ratios. Although operational performance has been commendable, Ambit believes valuations are running ahead of fundamentals.
Key Financial Highlights & Valuation Metrics
| Metric | Estimate / Value | Commentary |
|---|---|---|
| Target Price | ₹337 | Implied 18% revenue CAGR over two decades |
| IPO Price | ₹402 | Premium valuation vs peers |
| Capex (FY25–28) | ₹2,000 Cr | Free cash flow negative until FY28 |
| RoCE / RoIC | 9% / 13% | Lag peers with 35–40% returns |
| EV/EBITDA FY28E | 55× (India) / 22× (Intl) | Rich multiples vs Trent & Nykaa |
Revenue Growth ~20% CAGR (FY25–28): Driven by continued market penetration and operating leverage benefits.
EBITDA Improvement 630 bps: Supported by gross margin gains and better scale efficiency.
Free Cash Flow Impact: ₹2,000 Cr capex plan could keep cash flows negative through FY28.
Valuation Concern: Ambit finds current market price hard to justify relative to return ratios.
Active investors tracking new listings can review momentum trades via the Nifty Option Level.
Peer Comparison Snapshot
| Company | Category | FY28E EV/EBITDA |
|---|---|---|
| Lenskart | Eyewear Retail | 55× |
| Trent Ltd | Fashion Retail | ~40× |
| Nykaa | Beauty & Care | ~35× |
| EssilorLuxottica | Global Eyewear | ~22× |
While Lenskart’s growth profile is impressive, its valuation far outpaces listed peers. Ambit foresees limited upside until profitability metrics align with sector leaders.
Strengths & Weaknesses
Strengths
|
Weaknesses
|
Despite operational progress, Ambit believes investors should weigh valuation risk against growth visibility before entering post-listing.
Opportunities & Threats
|
|
Market response to Lenskart’s listing will likely define sentiment toward consumer tech-retail valuations in the coming quarters.
Valuation & Investment View
- Short-term: Limited upside; valuation premium restricts gains post-listing.
- Medium-term: Neutral until RoCE improves to peer levels.
- Long-term: Positive if global expansion yields sustainable cash flows post FY28.
For sectoral momentum traders, track the BankNifty Option Level for directional cues.
Valuation risk remains the dominant factor in the near term, though Lenskart’s long-term story in premium eyewear retail is intact.
Investor Takeaway
Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Registered Investment Adviser, notes that while Lenskart’s growth outlook is solid, investors should await better valuations post listing for an optimal entry point. Explore more insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions.
